Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
<< anterior 21 a 40 de 153 siguiente >>
Presentar resultados
Seleccionar todas
21.Tiene citas relacionadas
van Zanten SV. Dyspepsia and reflux in primary care: rough DIAMOND of a trial. Lancet 2009;373:187-8. [Ref.ID 85041]
22.Tiene citas relacionadas Cita con resumen
Metz DC. Clostridium difficile colitis: wash your hand before stopping the proton pump inhibitor. Am J Gastroenterol 2008;103:2314. [Ref.ID 84419]
23.Tiene citas relacionadas Cita con resumen
Aseeri M, Schroeder T, Kramer J, Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008;103:2308-13. [Ref.ID 84418]
24. Cita con resumen
Kmietowicz Z. Company managed to block development of generic drug. BMJ 2008;336:576. [Ref.ID 82371]
26. Cita con resumen
Kontoghiorghes GJ. Deferasirox: uncertain future following renal failure fatalities, agranulocytosis and other toxicities. Expert Opin Drug Saf 2007;6:235-9. [Ref.ID 80688]
27.Tiene citas relacionadas Cita con resumen
Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91. [Ref.ID 80570]
28. Cita con resumen
Anónimo. Schering-Plough cholesterol franchise shows signs of pressure. Scrip 2007;3230:9. [Ref.ID 79137]
29.
Fulco PP, Vora UB, Bearman GML. Acid suppressive therapy and the effects on protease inhibitors. Ann Pharmacother 2006;40:1974-83. [Ref.ID 78741]
30.
Gisbert JP. Tratamiento farmacológico de la hemorragia digestiva por úlcera péptica. Med Clin (Barc) 2006;127:66-75. [Ref.ID 77359]
31. Cita con resumen
Ibáñez L, Vidal X, Vendrell L, Moretti U, Laporte JR, on behalf of the Spanish-Italian Collaborative Group for the Epidemiology of Gastrointestinal Bleeding. Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment Pharmacol Ther 2006;23:235-42. [Ref.ID 76599]
32. Cita con resumen
Laheij RJF, Sturkenboom MCJM, Hassing RJ, Dieleman J, Stricker BHC, Jansen JBMJ. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004;292:1955-60. [Ref.ID 71724]
33. Cita con resumen
Carvajal A, Martín Arias LH, Vega E, García Sánchez JA, Martín Rodríguez I, García Ortega P, García del Pozo J. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. Eur J Clin Pharmacol 2004;60:439-44. [Ref.ID 71396]
34.
Giroldini R. Il reflusso gastroesofageo nel bambino. Informazioni sui Farmaci 2004;28:84-8. [Ref.ID 71097]
35.
Anónimo. Influence des effets des médicaments sur la pratique de la plongée sous-marine. Bulletin d'Information du Médicament et de Pharmacovigilance CRIM Rennes 2004;113:1-4. [Ref.ID 70597]
36. Cita con resumen
Roughead E E, McGeechan K, Sayer GP. Bisphosphonate use and subsequent prescription of acid suppressants. Br J Clin Pharmacol 2004;57:813-6. [Ref.ID 70378]
37. Cita con resumen
Roberts C G, Ladenson PW. Hypothyroidism. Lancet 2004;363:793-803. [Ref.ID 69359]
38.
Reinke C M, Breitkreutz J, Leuenberger H. Aluminium in over-the-counter drugs: risks outweigh benefits?. Drug Saf 2003;26:1011-25. [Ref.ID 68309]
39.
Stanghellini V, De Ponti F, De Giorgio R, Barbara G, Tosetti C, Corinaldesi R. New developments in the treatment of functional dyspepsia. Drugs 2003;63:869-92. [Ref.ID 66413]
40.
Snell P, Oo C, Dorr A, Barrett J. Lack of pharmacokinetic interaction between the oral anti-influenza neuraminidase inhibitor prodrug oseltamivir and antacids. Br J Clin Pharmacol 2002;54:372-7. [Ref.ID 63839]
Seleccionar todas
 
<< anterior 21 a 40 de 153 siguiente >>